This expansion will change the trajectory of MASH by focusing on early detection, diagnosis, and access to care.

The collaboration will create a path from concept to preclinical development of complex diseases in the Biopharmaceutical ...

Sanyou Biopharmaceuticals, a Shanghai-based biopharmaceutical company specializing in biologics R&D, signed a strategic ...

Rod Ketner on Serán BioScience’s science-first culture and what biotechs should look for in a CDMO.